EUVIMEDEUVIMED entdecken
Crossref

Discovery and biological evaluation of HS13 as a novel covalent ligand targeting the NSD2-PWWP1 domain

Chang Liu, Qian Wang, Xinhua Xie, Huiling Wang, Siying Liu, Boyi Li, Jinrong Min, Xin Chen, Yunyuan Huang

Bioorganic & Medicinal Chemistry · 2026-10 · 141 · 118751

DOI: 10.1016/j.bmc.2026.118751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry, 2026-10. Verfasst von Chang Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Pesticide and Chemical Biology of Ministry of Education, Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School…. Hauptthemen laut MEDLINE: Histone-Lysine N-Methyltransferase, Repressor Proteins, Antineoplastic Agents, Drug Discovery. Die Arbeit nennt 21 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The PWWP1 domain of NSD2 is an epigenetic reader essential for the subcellular localization of NSD2 and is frequently implicated in oncogenesis, making it an attractive therapeutic target. Our previous work has identified the C294 residue of NSD2-PWWP1 as a viable covalent targeting site. In this study, we screened a library of 968 covalent compounds and identified the lead compound, 92-B7, which exhibited an IC50 of 332 μM. Subsequent structural optimization and affinity-guided evaluations led to the development of HS13, which demonstrated significantly improved potency with a Kd of 8.33 μM. Binding assays confirmed that HS13 selectively formed a covalent bond with C294. In cellular studies, HS13 inhibited U2OS cell proliferation, induced apoptosis, and triggered G2-phase cell cycle arrest. Strikingly, HS13 treatment also prompted the degradation of NSD2, likely through destabilization of the PWWP1 domain. Collectively, these findings demonstrate that HS13 functions as a covalent modulator of NSD2-PWWP1 and highlight covalent targeting of this domain as a promising therapeutic strategy against NSD2-driven cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone-Lysine N-MethyltransferaseRepressor ProteinsAntineoplastic AgentsDrug DiscoveryHumansCell ProliferationLigandsStructure-Activity RelationshipProtein DomainsApoptosisMolecular StructureCell Line, TumorDose-Response Relationship, DrugDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

Aromatic cageCovalent allostericPWWP domain

Substanzen

Histone-Lysine N-MethyltransferaseNSD2 protein, humanLigandsRepressor ProteinsAntineoplastic Agents

Autor:innen und Institutionen

  • Key Laboratory of Pesticide and Chemical Biology of Ministry of Education, Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan 430079, Chin…
  • State Key Laboratory of Bioactive Molecules and Druggability Assessment, College of Pharmacy, Jinan University, Guangzhou 510632, China.
  • State Key Laboratory of Green Pesticide, Key Laboratory of Pesticide & Chemical Biology of Ministry of Education, Hubei International Scientific and Technological Cooperation Base of Pesticide and Green Synthesis, Colle…
  • State Key Laboratory of Bioactive Molecules and Druggability Assessment, College of Pharmacy, Jinan University, Guangzhou 510632, China. Electronic address: chenxin2023@jnu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, C., Wang, Q., Xie, X., Wang, H., Liu, S., Li, B., Min, J., Chen, X., & Huang, Y. (2026). Discovery and biological evaluation of HS13 as a novel covalent ligand targeting the NSD2-PWWP1 domain. Bioorganic & Medicinal Chemistry, 141, 118751. https://doi.org/10.1016/j.bmc.2026.118751

Vancouver

Liu C, Wang Q, Xie X, Wang H, Liu S, Li B, et al. Discovery and biological evaluation of HS13 as a novel covalent ligand targeting the NSD2-PWWP1 domain. Bioorganic & Medicinal Chemistry. 2026;141:118751. doi:10.1016/j.bmc.2026.118751

BibTeX
@article{Liu2026,
  author = {Liu, Chang and Wang, Qian and Xie, Xinhua and Wang, Huiling and Liu, Siying and Li, Boyi and Min, Jinrong and Chen, Xin and Huang, Yunyuan},
  title = {Discovery and biological evaluation of HS13 as a novel covalent ligand targeting the NSD2-PWWP1 domain},
  journal = {Bioorganic & Medicinal Chemistry},
  year = {2026},
  volume = {141},
  pages = {118751},
  doi = {10.1016/j.bmc.2026.118751}
}
Kostenlos starten →